275 related articles for article (PubMed ID: 22951905)
21. ΔNp63α utilizes multiple mechanisms to repress transcription in squamous cell carcinoma cells.
Gallant-Behm CL; Espinosa JM
Cell Cycle; 2013 Feb; 12(3):409-16. PubMed ID: 23324337
[TBL] [Abstract][Full Text] [Related]
22. Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin.
Folk WP; Kumari A; Iwasaki T; Pyndiah S; Johnson JC; Cassimere EK; Abdulovic-Cui AL; Sakamuro D
J Biol Chem; 2019 Apr; 294(14):5700-5719. PubMed ID: 30733337
[TBL] [Abstract][Full Text] [Related]
23. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
24. Phospho-ΔNp63α regulates AQP3, ALOX12B, CASP14 and CLDN1 expression through transcription and microRNA modulation.
Ratovitski EA
FEBS Lett; 2013 Nov; 587(21):3581-6. PubMed ID: 24070899
[TBL] [Abstract][Full Text] [Related]
25. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
26. ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis.
Pabla N; Huang S; Mi QS; Daniel R; Dong Z
J Biol Chem; 2008 Mar; 283(10):6572-83. PubMed ID: 18162465
[TBL] [Abstract][Full Text] [Related]
27. U-box-type ubiquitin E4 ligase, UFD2a attenuates cisplatin mediated degradation of DeltaNp63alpha.
Chatterjee A; Upadhyay S; Chang X; Nagpal JK; Trink B; Sidransky D
Cell Cycle; 2008 May; 7(9):1231-7. PubMed ID: 18418053
[TBL] [Abstract][Full Text] [Related]
28. DeltaNp63 transcriptionally regulates ATM to control p53 Serine-15 phosphorylation.
Craig AL; Holcakova J; Finlan LE; Nekulova M; Hrstka R; Gueven N; DiRenzo J; Smith G; Hupp TR; Vojtesek B
Mol Cancer; 2010 Jul; 9():195. PubMed ID: 20663147
[TBL] [Abstract][Full Text] [Related]
29. ATM kinase is a master switch for the Delta Np63 alpha phosphorylation/degradation in human head and neck squamous cell carcinoma cells upon DNA damage.
Huang Y; Sen T; Nagpal J; Upadhyay S; Trink B; Ratovitski E; Sidransky D
Cell Cycle; 2008 Sep; 7(18):2846-55. PubMed ID: 18769144
[TBL] [Abstract][Full Text] [Related]
30. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of ataxia-telangiectasia mutated by antisense oligonucleotide nanoparticles induces radiosensitization of head and neck squamous-cell carcinoma in mice.
Zou J; Qiao X; Ye H; Zhang Y; Xian J; Zhao H; Liu S
Cancer Biother Radiopharm; 2009 Jun; 24(3):339-46. PubMed ID: 19435407
[TBL] [Abstract][Full Text] [Related]
32. Ataxia telangiectasia mutated impacts insulin-like growth factor 1 signalling in skeletal muscle.
Ching JK; Luebbert SH; Collins RL; Zhang Z; Marupudi N; Banerjee S; Hurd RD; Ralston L; Fisher JS
Exp Physiol; 2013 Feb; 98(2):526-35. PubMed ID: 22941977
[TBL] [Abstract][Full Text] [Related]
33. Phospho-ΔNp63α/microRNA network modulates epigenetic regulatory enzymes in squamous cell carcinomas.
Ratovitski EA
Cell Cycle; 2014; 13(5):749-61. PubMed ID: 24394434
[TBL] [Abstract][Full Text] [Related]
34. Antisense inhibition of ATM gene enhances the radiosensitivity of head and neck squamous cell carcinoma in mice.
Zou J; Qiao X; Ye H; Yang Y; Zheng X; Zhao H; Liu S
J Exp Clin Cancer Res; 2008 Oct; 27(1):56. PubMed ID: 18950535
[TBL] [Abstract][Full Text] [Related]
35. Resistance to DNA-damaging treatment in non-small cell lung cancer tumor-initiating cells involves reduced DNA-PK/ATM activation and diminished cell cycle arrest.
Lundholm L; Hååg P; Zong D; Juntti T; Mörk B; Lewensohn R; Viktorsson K
Cell Death Dis; 2013 Jan; 4(1):e478. PubMed ID: 23370278
[TBL] [Abstract][Full Text] [Related]
36. ATM-dependent and -independent dynamics of the nuclear phosphoproteome after DNA damage.
Bensimon A; Schmidt A; Ziv Y; Elkon R; Wang SY; Chen DJ; Aebersold R; Shiloh Y
Sci Signal; 2010 Dec; 3(151):rs3. PubMed ID: 21139141
[TBL] [Abstract][Full Text] [Related]
37. NPRL2 sensitizes human non-small cell lung cancer (NSCLC) cells to cisplatin treatment by regulating key components in the DNA repair pathway.
Jayachandran G; Ueda K; Wang B; Roth JA; Ji L
PLoS One; 2010 Aug; 5(8):e11994. PubMed ID: 20700484
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylated TP63 induces transcription of RPN13, leading to NOS2 protein degradation.
Huang Y; Ratovitski EA
J Biol Chem; 2010 Dec; 285(53):41422-31. PubMed ID: 20959455
[TBL] [Abstract][Full Text] [Related]
39. DeltaNp63alpha-mediated induction of epidermal growth factor receptor promotes pancreatic cancer cell growth and chemoresistance.
Danilov AV; Neupane D; Nagaraja AS; Feofanova EV; Humphries LA; DiRenzo J; Korc M
PLoS One; 2011; 6(10):e26815. PubMed ID: 22053213
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of poly(ADP-ribose) polymerase (PARP) and ataxia telangiectasia mutated (ATM) on the chemosensitivity of mantle cell lymphoma to agents that induce DNA strand breaks.
Golla RM; Li M; Shen Y; Ji M; Yan Y; Fu K; Greiner TC; McKeithan TW; Chan WC
Hematol Oncol; 2012 Dec; 30(4):175-9. PubMed ID: 22170260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
